Literature DB >> 21464752

Risk factors for parenteral nutrition–associated liver disease following surgical therapy for necrotizing enterocolitis: A Glaser Pediatric Research Network Study [corrected].

Debora Duro1, Paul D Mitchell, Leslie A Kalish, Cami Martin, Maggie McCarthy, Tom Jaksic, James Dunn, Mary L Brandt, Kerilyn K Nobuhara, Karl G Sylvester, R Lawrence Moss, Christopher Duggan.   

Abstract

OBJECTIVE: The aim of the study was to prospectively determine risk factors for the development of parenteral nutrition-associated liver disease (PNALD) in infants who underwent surgery for necrotizing enterocolitis (NEC), the most common cause of intestinal failure in children. PATIENTS AND METHODS: : From February 2004 to February 2007, we diagnosed 464 infants with NEC, of whom 180 had surgery. One hundred twenty-seven patients were available for full analysis. PNALD was defined as serum direct bilirubin ≥ 2 mg/dL or ALT ≥ 2 × the upper limit of normal in the absence of sepsis after ≥ 14 days of exposure to PN.
RESULTS: Median gestational age was 26 weeks and 68% were boys. Seventy percent of the cohort developed PNALD and the incidence of PNALD varied significantly across the 6 study sites, ranging from 56% to 85% (P = 0.05). Multivariable logistic regression analysis identified small-bowel resection or creation of jejunostomy (odds ratio [OR] 4.96, 95% confidence interval [CI] 1.97-12.51, P = 0.0007) and duration of PN in weeks (OR 2.37, 95% CI 1.56-3.60, P < 0.0001) as independent risk factors for PNALD. Preoperative exposure to PN was also associated with the development of PNALD; the risk of PNALD was 2.6 (95% CI 1.5-4.7; P = 0.001) times greater in patients with ≥ 4 weeks of preoperative PN compared with those with less preoperative PN use. Breast milk feedings, episodes of infection, and gestational age were not related to the development of PNALD.
CONCLUSIONS: The incidence of PNALD is high in infants with NEC undergoing surgical treatment. Risk factors for PNALD are related to signs of NEC severity, including the need for small-bowel resection or proximal jejunostomy, as well as longer exposure to PN. Identification of these and other risk factors can help in the design of clinical trials for the prevention and treatment of PNALD and for clinical assessment of patients with NEC and prolonged PN dependence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21464752      PMCID: PMC3444282          DOI: 10.1097/MPG.0b013e31820e8396

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  20 in total

Review 1.  Nutritional factors contributing to the development of cholestasis during total parenteral nutrition.

Authors:  Maria Luisa Forchielli; W Allan Walker
Journal:  Adv Pediatr       Date:  2003

Review 2.  Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation.

Authors:  Alan L Buchman; Kishore Iyer; Jonathan Fryer
Journal:  Hepatology       Date:  2006-01       Impact factor: 17.425

3.  Development of hepatic cholestasis and fibrosis in patients with massive loss of intestine supported by prolonged parenteral nutrition.

Authors:  R T Stanko; G Nathan; H Mendelow; S A Adibi
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

4.  Influence of bacterial overgrowth and intestinal inflammation on duration of parenteral nutrition in children with short bowel syndrome.

Authors:  S S Kaufman; C A Loseke; J V Lupo; R J Young; N D Murray; L W Pinch; J A Vanderhoof
Journal:  J Pediatr       Date:  1997-09       Impact factor: 4.406

5.  Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors.

Authors:  S V Beath; P Davies; A Papadopoulou; A R Khan; R G Buick; J J Corkery; P Gornall; I W Booth
Journal:  J Pediatr Surg       Date:  1996-04       Impact factor: 2.545

6.  Effect of total parenteral nutrition on gut hormone release in humans.

Authors:  G R Greenberg; S L Wolman; N D Christofides; S R Bloom; K N Jeejeebhoy
Journal:  Gastroenterology       Date:  1981-05       Impact factor: 22.682

7.  Outcome and long-term growth after extensive small bowel resection in the neonatal period: a survey of 87 children.

Authors:  O Goulet; S Baglin-Gobet; C Talbotec; L Fourcade; V Colomb; F Sauvat; J-P Jais; J-L Michel; D Jan; C Ricour
Journal:  Eur J Pediatr Surg       Date:  2005-04       Impact factor: 2.191

8.  Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience.

Authors:  Rubén E Quirós-Tejeira; Marvin E Ament; Laurie Reyen; Faye Herzog; Michelle Merjanian; Nancy Olivares-Serrano; Jorge H Vargas
Journal:  J Pediatr       Date:  2004-08       Impact factor: 4.406

Review 9.  Causes and management of intestinal failure in children.

Authors:  Olivier Goulet; Frank Ruemmele
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

10.  Improved survival in very short small bowel of infancy with use of long-term parenteral nutrition.

Authors:  S F Dorney; M E Ament; W E Berquist; J H Vargas; E Hassall
Journal:  J Pediatr       Date:  1985-10       Impact factor: 4.406

View more
  21 in total

Review 1.  Routine monitoring of gastric residual for prevention of necrotising enterocolitis in preterm infants.

Authors:  Thangaraj Abiramalatha; Sivam Thanigainathan; Binu Ninan
Journal:  Cochrane Database Syst Rev       Date:  2019-07-09

2.  Postoperative Enteral Nutrition Guidelines Reduce the Risk of Intestinal Failure-Associated Liver Disease in Surgical Infants.

Authors:  Darla R Shores; Samuel M Alaish; Susan W Aucott; Janine E Bullard; Courtney Haney; Heidi Tymann; Bareng A S Nonyane; Kathleen B Schwarz
Journal:  J Pediatr       Date:  2018-04       Impact factor: 4.406

3.  Association of Comorbidities With Adverse Outcomes After Enterostomy Closure in Premature Neonates.

Authors:  Donald J Lucas; Ankush Gosain
Journal:  JAMA Surg       Date:  2018-08-01       Impact factor: 14.766

4.  Aspiration and evaluation of gastric residuals in the neonatal intensive care unit: state of the science.

Authors:  Leslie Parker; Roberto Murgas Torrazza; Yuefeng Li; Elizabeth Talaga; Jonathan Shuster; Josef Neu
Journal:  J Perinat Neonatal Nurs       Date:  2015 Jan-Mar       Impact factor: 1.638

Review 5.  Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.

Authors:  Per T Sangild; Denise M Ney; David L Sigalet; Andreas Vegge; Douglas Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-23       Impact factor: 4.052

6.  Re-feeding versus discarding gastric residuals to improve growth in preterm infants.

Authors:  Thangaraj Abiramalatha; Sivam Thanigainathan; Umamaheswari Balakrishnan
Journal:  Cochrane Database Syst Rev       Date:  2019-07-08

7.  Intestinal Microbiota, Lipids, and the Pathogenesis of Intestinal Failure-Associated Liver Disease.

Authors:  Way Seah Lee; Ronald J Sokol
Journal:  J Pediatr       Date:  2015-06-27       Impact factor: 4.406

8.  Safety and efficacy of mucous fistula refeeding in low-birth-weight infants with enterostomies.

Authors:  Kiyoaki Yabe; Katsunori Kouchi; Ayako Takenouchi; Aki Matsuoka; Takahiro Korai; Chikako Nakata
Journal:  Pediatr Surg Int       Date:  2019-08-08       Impact factor: 1.827

9.  Prevention and treatment of intestinal failure-associated liver disease in children.

Authors:  Bram P Raphael; Christopher Duggan
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

10.  Predictors of failure of fish-oil therapy for intestinal failure-associated liver disease in children.

Authors:  Prathima Nandivada; Meredith A Baker; Paul D Mitchell; Alison A O'Loughlin; Alexis K Potemkin; Lorenzo Anez-Bustillos; Sarah J Carlson; Duy T Dao; Gillian L Fell; Kathleen M Gura; Mark Puder
Journal:  Am J Clin Nutr       Date:  2016-08-10       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.